Cookson Peirce & Co’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-397,688
Closed -$41M 165
2020
Q3
$41M Buy
397,688
+46,572
+13% +$4.87M 3.08% 10
2020
Q2
$35.6M Buy
351,116
+98,356
+39% +$8.8M 3.34% 8
2020
Q1
$17M Buy
+252,760
New +$15.7M 1.95% 21

Other funds holding DXCM

Cookson Peirce & Co's DXCM Position: Q4 2020 in Review

Cookson Peirce & Co sold out of DexCom (DXCM) in Q4 2020, closing a stake of 397,688 shares — an estimated $41M sold.

Cookson Peirce & Co first reported a position in DXCM in Q1 2020 and held it in 3 quarters. The position peaked at $41M in Q3 2020. 733 funds tracked by Wall St. Rank hold DXCM as of Q4 2020.

  • Cookson Peirce & Co reported no remaining DexCom position as of Q4 2020 after selling out during the quarter.
  • Cookson Peirce & Co sold 397,688 DexCom shares in Q4 2020, an estimated $41M.
  • Cookson Peirce & Co first reported a position in DexCom in Q1 2020 and held it in 3 quarters.
  • Cookson Peirce & Co's DexCom position peaked at $41M in Q3 2020.
  • 733 funds tracked by Wall St. Rank held DexCom as of Q4 2020.

Based on Cookson Peirce & Co's 13F filing for Q4 2020, filed 10 Feb 2021.